Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1808.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,319.0,1.0,=,5.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1260.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,201.0,1.0,=,6.3
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2651.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,482.0,1.0,=,5.5
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3242.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,891.0,1.0,=,3.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2270.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,494.0,1.0,=,4.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2610.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,484.0,1.0,=,5.4
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1215.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,320.0,1.0,=,3.8
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1046.0,1.0,Mu,95,T95I + Y144T + Y145S + H146N + R346K + E484K + N501Y + P681H + D950N,1,=,186.0,1.0,=,5.6